Clinical data
Other names
MDL-72,974A
Oral[1]
Legal status
Pharmacokinetic data
1–3 hours[1]
Urine[2]
Identifiers
(2E)-2-(fluoromethylidene)-4-(4-fluorophenyl)butan-1-amine
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
C11H13F2N
197.229 g·mol−1
3D model (JSmol)
Fc1ccc(cc1)CCC(=[C@H]F)CN
InChI=1S/C11H13F2N/c12-7-10(8-14)2-1-9-3-5-11(13)6-4-9/h3-7H,1-2,8,14H2/b10-7+
Key:VXLBSYHAEKDUSU-JXMROGBWSA-N
Mofegiline (MDL-72,974) is a selective, irreversible inhibitorofmonoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease,[3][4][5][6] but was never marketed.[7]
Food antioxidants
Fuel antioxidants
Measurements
AChE inhibitor medications
Other medications
Experimental BACE inhibitors
Others
Non-specific
AAADTooltip Aromatic L-amino acid decarboxylase
MAOTooltip Monoamine oxidase
PAHTooltip Phenylalanine hydroxylase
THTooltip Tyrosine hydroxylase
DBHTooltip Dopamine beta-monooxygenase
PNMTTooltip Phenylethanolamine N-methyltransferase
COMTTooltip Catechol-O-methyl transferase
TPHTooltip Tryptophan hydroxylase
AANATTooltip Serotonin N-acetyl transferase
ASMTTooltip Acetylserotonin O-methyltransferase
HDCTooltip Histidine decarboxylase
HNMTTooltip Histamine N-methyltransferase
DAOTooltip Diamine oxidase